Clinical Trials Logo

Filter by:
NCT ID: NCT06216067 Completed - Cataract Clinical Trials

Evaluate Performance of Callisto Eye vs. Wavetec AnalyzOR

CORTCO
Start date: December 14, 2021
Phase:
Study type: Observational

The goal of this clinical trial is to evaluate two separate operating room cataract measuring tools in predicting the residual astigmatism (prediction error) in patients with corneal astigmatism. The main question it aims to answer is: Show the refractive predictability comparing the use of Operating Room cataract toric lens placement tools against the standard manual technique. Participants will be implanted with the TECNIS Toric II IOL Lens Model ZCU; the second eye, if applicable, is to be implanted within 45 days of the first-eye surgery. Researchers will compare two Operating Room cataract lens placement tools: the Zeiss CALLISTO vs. the Wavetec AnalyzOR to determine refractive predictability.

NCT ID: NCT06215911 Recruiting - Heart Failure Clinical Trials

A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)

Cycle-1-REF
Start date: February 13, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic heart failure with reduced ejection fraction.

NCT ID: NCT06215859 Recruiting - Pain Clinical Trials

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Start date: December 29, 2023
Phase: Phase 3
Study type: Interventional

MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after herniorrhaphy.

NCT ID: NCT06215820 Recruiting - Pain Clinical Trials

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Start date: December 29, 2023
Phase: Phase 3
Study type: Interventional

MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after bunionectomy.

NCT ID: NCT06215716 Recruiting - NASH With Fibrosis Clinical Trials

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Start date: December 1, 2023
Phase: Phase 3
Study type: Interventional

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3.

NCT ID: NCT06215703 Recruiting - Stroke Clinical Trials

Optimizing Music-Based Interventions for Stroke

OptiMUS
Start date: February 16, 2024
Phase: N/A
Study type: Interventional

This study will enroll stroke patients and healthy participants. Participants will complete baseline measures followed by a music playing task during fMRI and simultaneous measurement of motor response using electromyography (EMG) and accelerometry and affective response using electrodermal activity (EDA) and self-reports. The music task consists of tapping an MRI-compatible MIDI drum with either: (1) improvisation or maintaining the beat and (2) live or recorded piano accompaniment. The primary objectives are to identify the motor, affective, and neural outcomes of improvisation and live accompaniment in music playing tasks.

NCT ID: NCT06215664 Not yet recruiting - Binge Drinking Clinical Trials

Game-Based Intervention to Reduce Alcohol Use Among Sexual and Gender Minority Youth

Start date: January 6, 2025
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to examine the efficacy of a game-based intervention to reduce alcohol use among sexual and gender minority youth.

NCT ID: NCT06215586 Recruiting - Heart Failure Clinical Trials

Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)

Cycle-2-PEF
Start date: February 13, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic heart failure with preserved ejection fraction

NCT ID: NCT06215560 Not yet recruiting - Medication Abuse Clinical Trials

A Prospective Evaluation of Colorado's New Statutory PDMP Mandates: Compliance and Patient Outcomes

Start date: August 2024
Phase:
Study type: Observational

The goal of this study is to test the impact of a clinical decision support (CDS) tool to improve health care provider practices in line with state law requiring review of the Colorado prescription drug monitoring program (PDMP) before prescribing an opioid analgesic (pain medications often called narcotics) or benzodiazepine (sedatives or muscle relaxants). The PDMP is a statewide database of filled controlled medication, allowing health care providers to review medications ordered by other health care providers in the state and identify high-risk factors for overdose. The CDS tool only appears when a relevant prescription is being written by a health care provider and is purely informational, not dictating care or changes in treatment. The study will track how the tool is used by health care providers, if an opioid or benzodiazepine prescription is signed, and future opioid use by patients.

NCT ID: NCT06215547 Enrolling by invitation - Gastroparesis Clinical Trials

Medtronic Enterra II Neurostimulator

Start date: September 15, 2015
Phase: N/A
Study type: Interventional

Humanitarian Device: Authorized by Federal (U.S.A.) Law for use in treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology.